Why Choose M3TRIQ
AI-Powered Discovery Platform
Automates ligand discovery targeting specific protein pathways using advanced neural models.
Cross-Industry Scalability
Applies across biomaterials, therapeutics, and industrial biomanufacturing with minimal customization.
Lower Cost – Up to 80%
Dramatically reduces the cost of high-performance ligands without compromising quality.
Solving Real Business Challenges
Cost-Scale Paradox
Cutting reliance on expensive recombinant proteins and reducing per-liter media costs dramatically.
Slow and Risky R&D Cycles
Provides an in-silico media prototyping engine that rapidly screens molecules for biological function, stability, and scalability—reducing time-to-decision and R&D cost by up to 60%.
Regulatory and Scale-Up Bottlenecks
Integrates regulatory intelligence into media optimization—flagging GRAS-compatible inputs and simulating bioreactor-scale conditions early, enabling smoother tech transfer and faster regulatory pathways.
Proprietary Technology
De Novo Ligand Discovery Engine
Designs AI-generated small molecules that mimic growth factors, optimized for receptor binding, species compatibility, and food safety.
Functional Assay Simulation Layer
Predicts cell growth and differentiation outcomes using AI models trained on wet-lab data, reducing trial-and-error and lab costs.
Media Cost-Efficacy Optimizer
Uses reinforcement learning to balance ingredient cost, chemical stability, and biological performance for scalable media formulations.
Regulatory-Aware Design Filter
Screens for ingredients with FDA, GRAS, or EFSA precedent to ease regulatory approval and accelerate commercialization.
Meet the Team
